Literature DB >> 29560799

Gastric cancer: factors affecting survival.

Suleyman Orman1, Haci Murat Cayci2.   

Abstract

BACKGROUND AND AIM: The present multicenter, retrospective study aimed at determining the factors affecting survival in patients who were operated on due to gastric cancer (GC). PATIENTS AND METHODS: The data of 234 patients, who underwent elective surgery due to GC were retrospectively analyzed. The demographic characteristics, tumor localization and diameter, type of resection and lymph node dissection, experience of the operating surgeon (senior or junior), tumor grade, pT stage, number of lymph nodes harvested, number of lymph nodes with and without metastasis, tumor stage and survival data were recorded.
RESULTS: Survival was better a tumor diameter <4 cm, lower localization, experience of the operating surgeon (senior), without metastatic lymph nodes, tumor grade and decreased invasion depth (p < .05). There was no statistically significant difference between D1 LND and D2 LND with respect to survival (p = .793). Mortality was higher and survival was lower in patients with metastatic lymph nodes (p = .001). A number of harvested lymph nodes of 16 or more increased mortality (p = .003). Also, as disease stage increased, there was a decrease in survival and increase in mortality rates (p = .001).
CONCLUSIONS: Survival outcomes in resectable GCs are affected by the experience of the surgeon and patient-related factors at the time of surgery, including tumor size, T stage, and presence of metastatic lymph nodes.

Entities:  

Keywords:  Gastric cancer; stage; surgery; survival

Mesh:

Year:  2018        PMID: 29560799     DOI: 10.1080/00015458.2018.1453437

Source DB:  PubMed          Journal:  Acta Chir Belg        ISSN: 0001-5458            Impact factor:   1.090


  6 in total

1.  Overexpression of lncRNA TCLlnc1 in gastric cancer predicts postoperative distant recurrence and poor survival.

Authors:  Kan Hu; Yugui Zhang; Jun Rong; Wensheng Deng; Benping Xiao
Journal:  Anticancer Drugs       Date:  2022-09-05       Impact factor: 2.389

2.  CircRNA_0043691 sponges miR-873-3p to promote metastasis of gastric cancer.

Authors:  Yu Zhang; Gengyuan Hu; Zhenxing Zhang; Yuanming Jing; Feng Tao; Minfeng Ye
Journal:  Mamm Genome       Date:  2021-08-09       Impact factor: 2.957

3.  Application of Parametric Shared Frailty Models to Analyze Time-to-Death of Gastric Cancer Patients.

Authors:  Mesfin Esayas Lelisho; Geremew Muleta Akessa; Demeke Kifle Demissie; Samuel Fikadu Yermosa; Solomon Abebaw Andargie; Seid Ali Tareke; Digvijay Pandey
Journal:  J Gastrointest Cancer       Date:  2022-01-22

4.  A study of outcomes, technical safety, and feasibility of D-2 lymphadenectomy in gastric cancer.

Authors:  Abhijit Talukdar; Srinivas Bannoth; Joydeep Purkayastha; Bibhuti B Borthakur; Deepjyoti Kalita; Gaurav Das; Niju Pegu; Pritesh Singh
Journal:  JGH Open       Date:  2020-08-08

5.  A Substage Increase in The AJCC Classification System Improves Prognostic Prediction in Stage III Gastric Cancer With Insufficient Lymph Nodes Removed.

Authors:  Ri-Sheng Zhao; Yi-Nan Liu; Wei-Gang Dai; Si-Le Chen; Jin-Ning Ye; Er-Tao Zhai; Shi-Rong Cai; Jian-Hui Chen
Journal:  Front Oncol       Date:  2021-03-05       Impact factor: 6.244

6.  Comparison of Perioperative Chemotherapy versus Postoperative Chemoradiotherapy for Operable Stomach Cancer: A Western Canadian Province Experience.

Authors:  Adnan Zaidi; Amal Khan; Claire Duval; Kamal Haider; Osama Ahmed; Dorie-Anna Dueck; Bryan Brunet; Donald Gardiner; Shahid Ahmed
Journal:  Curr Oncol       Date:  2021-03-17       Impact factor: 3.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.